| dc.contributor.author | Saniee, S | |
| dc.contributor.author | Davarnia, G | |
| dc.date.accessioned | 2018-08-26T07:40:54Z | |
| dc.date.available | 2018-08-26T07:40:54Z | |
| dc.date.issued | 2016 | |
| dc.identifier | 10.1159/000452319 | |
| dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47303 | |
| dc.description.abstract | Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone. (C) 2016 The Author(s) Published by S. Karger AG, Basel | |
| dc.language.iso | English | |
| dc.relation.ispartof | CASE REPORTS IN DERMATOLOGY | |
| dc.subject | Scleromyxedema | |
| dc.subject | Paraproteinemia | |
| dc.subject | Mucinoses | |
| dc.subject | Thalidomide | |
| dc.title | Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone | |
| dc.type | Article | |
| dc.citation.volume | 8 | |
| dc.citation.issue | 3 | |
| dc.citation.spage | 327 | |
| dc.citation.epage | 332 | |
| dc.citation.index | Web of science | |
| dc.identifier.DOI | https://doi.org/10.1159/000452319 | |
